Planet Labs PBC enters the post-earnings week down another 9.5%, with the options market's pre-print distress signal now validated — and a put/call ratio that has climbed to a new 52-week high rather than retreating after the event.
The options setup is the most striking data point this week. The PCR hit 0.67 on June 16, a fresh 52-week peak that eclipses the 0.70 high referenced in the pre-earnings note and sits more than four standard deviations above the 20-day mean of 0.42. For context, the ratio ran between 0.35 and 0.44 for essentially all of May. The fact that put demand has accelerated after a confirmed 25% one-day drop — rather than unwinding — suggests hedging activity has shifted from pre-event caution to something more sustained. This is no longer the market pricing a binary; it looks more like continued defensive repositioning against a stock that has now fallen 32% in a month.
Short interest tells a less dramatic story, but confirms the direction. Bears have rebuilt their position through May: SI climbed roughly 16% over the past 30 days to reach 12.76% of the free float, up from around 10.9% in mid-May. On the week the move is negligible — flat to slightly down — which means the short book was already fully loaded heading into the June 4 earnings collapse and has held steady since. The borrow market remains relaxed. The cost to borrow is ticking up — rising 23% on the week to just 0.51% — but that's still negligible in absolute terms. Availability, at 164%, is well within normal range and has actually tightened somewhat from the 200%-plus readings of late May and early June, consistent with renewed lending demand as SI edged higher. There is no squeeze pressure here.
The Street is hanging on to its bullish framing, but the gap between analyst targets and price has widened sharply. The consensus mean target is $39.80, implying 41% upside from current levels around $28.21 — a spread that reflects the conviction behind the June 5 target raises from Needham (to $53) and Craig-Hallum (to $49), both firms stepping into the post-collapse gap. Goldman Sachs is the notable outlier, sitting at Neutral with a $20 target. Bulls frame PL as foundational AI-training infrastructure, pointing to defence and EMEA contract momentum and a satellite fleet that imagery customers cannot replicate. Bears flag what the earnings print confirmed: non-GAAP gross margins under pressure, negative EBITDA, and a cost structure that scales ahead of revenue. Factor scores reinforce the sceptic side — EPS momentum ranks in the bottom 3% of the universe on a 30-day basis, and the analyst recommendation differential is similarly weak at the 3rd percentile. The ORTEX short score has stabilised near 62.7, elevated but not at a historic extreme.
The institutional register offers one data point worth noting. Alphabet holds roughly 9.9% of shares outstanding, and BlackRock added a significant 5.2 million shares in a period ending May 31, bringing its stake to 7.1%. That passive and strategic anchor sits against an insider register that has been one-directional: the CEO, CFO, and co-founder all sold material positions in late March and early April, at prices between $27 and $35. Those sales happened close to current price levels, adding context to the current setup.
The next earnings event is scheduled for July 9. With the stock now trading below where most of the recent insider selling occurred, and the options market still pricing elevated downside risk, the key question heading into that print is whether the backlog and margin trajectory — the two variables that drove the June 4 selloff — have stabilised enough to narrow the gap between where the Street's bulls are anchored and where the stock is actually trading.
See the live data behind this article on ORTEX.
Open PL on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
